Envoy Medical (COCH) EBIT (2021 - 2026)
Envoy Medical (COCH) reported EBIT of -$6.0 million for Q1 2026, down 16.68% on a YoY basis from -$7.2 million in Q1 2025, and up 6.67% sequentially from -$6.4 million in Q4 2025.
Envoy Medical (COCH) EBIT (2021 - 2026) Analysis & Trends
Envoy Medical (COCH) has 6 years of EBIT data on file, last reported at -$6.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 16.68% year-over-year to -$6.0 million; the trailing twelve-month figure through Mar 2026 stood at -$23.1 million (down 18.7% YoY), and the FY2025 full-year result was -$22.3 million, down 15.65% from the prior year.
- EBIT improved to -$6.0 million in Q1 2026, from -$6.4 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$901356.0 in Q2 2022 to a low of -$6.7 million in Q4 2023.
- A 5-year average of -$4.3 million and a median of -$4.9 million in 2024 frame the typical range for EBIT.
- Across the five-year window, EBIT surged 39.86% in 2022 and plunged 397.03% in 2023, its largest moves.
- Tracing COCH's EBIT over 5 years: stood at -$2.9 million in 2022, then tumbled by 131.35% to -$6.7 million in 2023, then surged by 32.34% to -$4.5 million in 2024, then tumbled by 40.36% to -$6.4 million in 2025, then advanced by 6.67% to -$6.0 million in 2026.
- Business Quant data shows COCH's EBIT at -$6.0 million in Q1 2026, -$6.4 million in Q4 2025, and -$5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.96 Mn |
| Dec 31, 2025 | -6.39 Mn |
| Sep 30, 2025 | -5.71 Mn |
| Jun 30, 2025 | -5.07 Mn |
| Mar 31, 2025 | -5.11 Mn |
| Dec 31, 2024 | -4.55 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -4.85 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Dec 31, 2023 | -6.72 Mn |
| Sep 30, 2023 | -3.39 Mn |
| Jun 30, 2023 | -4.48 Mn |
| Mar 31, 2023 | -3.77 Mn |
| Dec 31, 2022 | -2.91 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | -901,356.00 |
| Mar 31, 2022 | -1.49 Mn |
| Dec 31, 2021 | -963,905.00 |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -1.07 Mn |